A Potential Effective And Innovative Therapy For The Treatment of Chronic HBV Infection And Liver Cancer

Sonia Li
2021 Zenodo  
In a study published in Nature Communications on May 14, a research team led by scientists from University College London (UCL) found a new target for the treatment of hepatitis B. The targeted therapy of HBV can not only inhibit the replication of HBV, but also stimulate T cell activity against HBV-infected liver cells. The researchers said that this target may bring a highly effective and innovative therapy for the treatment of chronic HBV infection and liver cancer.
doi:10.5281/zenodo.4925657 fatcat:tjq6y2ywjjaqvhiyjzjpzk75p4